Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial

Radiotherapy and Oncology

Volumn 90, Issue 1, 2009, Pages 80-85

  Poortmans, Philip M ^a   Collette, Laurence ^b   Horiot, Jean Claude ^c   Van den Bogaert, Walter F ^d   Fourquet, Alain ^e   Kuten, Abraham ^f   Noordijk, Evert M ^g   Hoogenraad, Willem ^h   Mirimanoff, René Olivier ⁱ   Pierart, Marianne ^b   Van Limbergen, Erik ^d   Bartelink, Harry ^j  

^a DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^b Centre Georges François Leclerc ^*

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

^d University Hospital Gasthuisberg   (France)

^e INSTITUT CURIE   (France)

^f RAMBAM MEDICAL CENTER   (Israel)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ EPFL   (Switzerland)

^j NETHERLANDS CANCER INSTITUTE   (Netherlands)

more..

Author keywords

Boost; Breast cancer; Breast conserving therapy; Incomplete resection; Radiotherapy; Randomised clinical trial

Indexed keywords

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FIBROSIS; FOLLOW UP; MICROSCOPY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE;

EID: 58149265075     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.07.011     Document Type: Article

References (32)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
2. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
3. Voogd A.C., Nielsen M., Peterse J.L., et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 19 (2001) 1688-1697
4. Early Breast Cancer Trialists Collaborative Group (EBCTCG). Effects of radiotherapy and differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trial. Lancet 2005;366:17-25.
5. Curran D., Van Dongen J.P., Aaronson N.K., et al. Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC trial 10801. Eur J Cancer 34 (1998) 307-314
6. Van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1145
7. Van Limbergen E., Van den Bogaert W., vander Schueren E., and Rijnders A. Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control. Radiother Oncol 8 (1987) 1-9
8. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
9. Bartelink H., Borger J.H., van Dongen J.A., and Peterse J.L. The Impact of tumor size and histology on local control after breast-conserving therapy. Radiother Oncol 11 (1988) 297-303
10. Newman L.A., and Kuerer H.M. Advances in breast conservation therapy. J Clin Oncol 23 (2005) 1685-1697
11. Van den Broek N., Van der Sangen M.J., Van de Poll-Franse L.V., van Beek M.W., Nieuwenhuijzen G.A., and Voogd A.C. Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 105 (2007) 63-68
12. TNM - classification of malignant tumours. 4th ed. Fully Revised Edition; 1987. p. 95-6.
13. International commission of radiation units and measurements: dose specification for reporting external beam therapy with photons and electrons. Report 50. ICRU Publication: Bethesda, MD, USA, 1992.
14. Harry B., Jean-Claude H., Philip P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387
15. Poortmans P.M., Ataman F., Davis J.B., et al. Quality assurance in the EORTC phase III randomised 'boost vs. no boost' trial for breast conserving therapy: comparison of the results of two individual case reviews performed early and late during the accrual period. Radiother Oncol 76 (2005) 278-284
16. Pocock S.J., and Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31 (1975) 103-115
17. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
18. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1141-1154
19. Schuck A., Ko ̈nemann S., Heinen K., et al. Strahlenther Onkol 178 (2002) 307-313
20. Van Limbergen E., van der Schueren E., Van den Bogaert W., and Van Wing J. Local control of operable breast cancer with radiotherapy only. Eur J Cancer 26 (1990) 674-679
21. DiBiase S.J., Komarnicky L.T., Schwartz G.F., et al. The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 82 (1998) 2212-2220
22. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18 (2000) 1668-1675
23. Solin L.J., Fowble B.L., Schultz D.J., et al. The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 21 (1991) 279-287
24. Santiago R.J., Wu L., Harris E., et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for stage 1 and II breast carcinoma: The University of Pennsylvania Experience. Int J Radiat Oncol Biol Phys 58 (2004) 233-240
25. Jones H, Antonini N, Colette L, et al. The impact of boost dose and margins on the local recurrence rate in breast conserving therapy: results from the EORTC Boost-No Boost Trial. Plenary oral presentation, 49th ASTRO-meeting. 28 October 2007-01 November 2007, Los Angeles. Int J Radiat Oncol Biol Phys 2007;69:abstract 2981.
26. Van Limbergen E., Rijnders A., Van der Schueren E., Lerut T., and Christiaens R. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 16 (1989) 253-267
27. Donovan E., Bleakley N., Denholm E., et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82 (2007) 254-264
28. Antonini N., Jones H., Horiot J.C., et al. Effect of age and radiation dose on local control after breast conserving treatment: EORTC Trial 22881-10882. Radiother Oncol 82 (2007) 265-271
29. Vrieling C., Collette L., Fourquet A., et al. Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?. Eur J Cancer 39 (2003) 932-944
30. Poortmans P., Bartelink H., Horiot J.C., et al. The influence of the boost technique on local control in breast conserving treatment in the EORTC "boost versus no boost" randomised trial. Radiother Oncol 72 (2004) 25-33
31. Hurkmans C.W., Meijer G.J., Van Vliet-Vroegindeweij C., Van der Sangen M.J., and Cassee J. High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys 66 (2006) 923-930
32. Van der Laan H.P., Dolsma W.V., Maduro J.H., Korevaar E.W., Hollander M., and Langendijk J.A. Three-dimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1018-1023